US2015328151A1PendingUtilityA1
Ophthalmic drug delivery
Est. expiryJul 15, 2030(~4 yrs left)· nominal 20-yr term from priority
A61P 27/02A61P 27/06A61P 31/04A61M 11/00G16H 30/20G16H 40/63A61K 8/06A61K 9/0048A61M 2210/0612G16H 20/10A61K 2300/00A61K 9/08A61F 9/00A61F 9/0008G16H 10/60G16H 15/00G16H 40/67A61K 39/395A61K 31/7052A61K 31/216A61K 31/4545A61K 31/5383A61K 31/56A61K 31/717A61K 31/5377A61K 31/382A61K 31/7036A61K 31/4709A61K 31/196A61K 31/498A61K 31/695A61K 38/13A61K 31/047A61K 31/55A61K 31/4402A61K 31/496A61K 33/30A61K 31/4409A61K 31/542A61K 31/4535A61K 31/4164A61K 31/165A61K 31/335A61K 31/245
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average initial ejecting velocity; and (b) delivering the medicament to the eye, where the droplets deliver a percentage of the ejected mass of the droplets to the eye.
Claims
exact text as granted — not AI-modified1 . A method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising:
(a) providing droplets containing said medicament, wherein said droplets have an average droplet size of at least about 15 microns and an average initial ejecting velocity between 1 m/s and 5 m/s; and (b) delivering said medicament to said eye, wherein between about 80% to about 100% of the ejected mass of said droplets are deposited on the eye.
2 .- 52 . (canceled)Join the waitlist — get patent alerts
Track US2015328151A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.